AITRIBOND
LIVE

Serial Number

79411798

Owner

Jiangsu Aidea Pharmaceutical Co., Ltd.

Attorney

Prakash NAMA

Filing Date

Sep 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AITRIBOND Trademark

Serial Number: 79411798 • Registration: 8035742

AITRIBOND is a trademark filed by Jiangsu Aidea Pharmaceutical Co., Ltd. on September 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Jiangsu Aidea Pharmaceutical Co., Ltd. (2 trademarks)

No. 69 Xin Ganquan West Road,

Entity Type: 03

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

No. 69 Xin Ganquan West Road,

Entity Type: 98

Trademark Details

Filing Date

September 3, 2024

Registration Date

November 25, 2025

Published for Opposition

October 7, 2025

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, chemical preparations for the treatment of HIV infection; Medicines for human purposes, namely, medicines for the treatment of HIV infection; Chemico-pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of HIV infection; Drugs for medical purposes, namely, antiretroviral drugs in the form of tablet for the treatment of HIV infection; Pharmaceutical preparations, namely, antiretroviral preparations for the treatment of HIV infection; Chemical preparations for medical purposes, namely, chemical preparations for the treatment of HIV infection; Antiviral preparations, namely, antivirals for the treatment of HIV infection; Pharmaceutical preparations for the treatment of immune system-related diseases and disorders; Antiviral drugs, namely, antivirals for the treatment of HIV infection; Medicines in the form of tablets, namely, antiretroviral tablets for the treatment of HIV infection; Active pharmaceutical ingredients (APIs), namely, antiretroviral drugs in the form of tablet for the treatment of HIV infection; Medicines for the treatment of viral diseases, namely, antiretroviral medicines for the treatment of HIV infection; Medicines for the treatment of infectious diseases, namely, antiretroviral medicines for the treatment of HIV infection.

Filing History

FINAL DISPOSITION NOTICE SENT TO IB
Jun 12, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 11, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 28, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 11, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 11, 2026 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 2, 2026 ADCH
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 25, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 29, 2025 TROA
REFUSAL PROCESSED BY IB
Jun 21, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 30, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 29, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 12, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 12, 2024 REPR